CHAD HUMMEL
Partner; Co-Leader, National Trial Practice
Sidley Austin LLP
Chad Hummel stands out for the exceptional results he has achieved for Sidley’s clients in numerous high impact litigations, trials and arbitrations during the contest period. Within the last 12 months alone, he served as lead trial counsel in seven separate arbitrations and trials and won them all – delivering hundreds of millions of dollars in value for his clients.
Hummel was lead trial counsel in a closely followed three-week arbitration in California’s bio-tech startup industry. The case arose out of the breakdown of a collaboration between Sidley’s client, Lyell Immunopharma and PACT Pharmaceuticals, which attempted to combine resources and find a cure for solid tumor cancers. Hummel’s team prevailed in the hotly-contested confidential arbitration in which it was proved that an investment of over $100 million by Lyell had been achieved in violation of California’s securities laws.
